Evidence map›Paper›PMID 34708098›Full record

ArticleFrontiers in cardiovascular medicine2021

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial.

Adam Hartley, Matthew Shun-Shin, Mikhail Caga-Anan, Christopher Rajkumar, Alexandra N Nowbar, Michael Foley, Darrel P Francis, Dorian O Haskard, Ramzi Y Khamis, Rasha K Al-Lamee

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Adam HartleyDepartment of Vascular Sciences, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Matthew Shun-ShinDepartment of Cardiovascular Trials and Epidemiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Mikhail Caga-AnanDepartment of Vascular Sciences, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Christopher RajkumarDepartment of Cardiovascular Trials and Epidemiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Alexandra N NowbarDepartment of Cardiovascular Trials and Epidemiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Michael FoleyDepartment of Cardiovascular Trials and Epidemiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Darrel P FrancisDepartment of Cardiovascular Trials and Epidemiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Dorian O HaskardDepartment of Vascular Sciences, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Ramzi Y KhamisDepartment of Vascular Sciences, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Rasha K Al-LameeDepartment of Cardiovascular Trials and Epidemiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Imperial College London · GB

Funding

Medical Research Council MR/S021108/1Medical Research Council MR/V001620/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atherosclerosisexerciseLDL-cholesterolmalondialdehyde-modified LDL (MDA-LDL)oxidised LDL (oxLDL)percutaneous coronary intervention (PCI)

Identifiers

PMID34708098
PMCPMC8542769
OpenAlexW3207693999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.